Joule Names Troy Campione Senior Vice President of Corporate Development

Cambridge, Mass. – January 27, 2010 – Joule today announced the appointment of Dr. Troy J. Campione as Senior Vice President of Corporate Development. In this newly-created role he will lead Joule’s business development strategy and execution, including the negotiation of partnership and development agreements across multiple market segments.

Dr. Campione’s extensive background in the fields of biotech and cleantech spans more than 20 years, including his most recent position as Senior Vice President of Business Development for Solazyme, a developer of algal-derived biofuels and other products. He previously spent more than six years at Symyx Technologies as General Manager and Vice President of Collaborations, Alliances and Licensing, and 15 years at ExxonMobil in a variety of business, operations and technology leadership roles across a range of Exxon’s energy and chemical technologies. He holds a PhD in Chemical Engineering from the University of Texas at Austin, and ME and BS degrees in Chemical Engineering from Tulane University.

“Troy’s relevant experience and knowledge of the industry will be tremendous assets as we advance towards commercialization and pursue the various market opportunities enabled by our multi-faceted product strategy and compelling story,” said Bill Sims, president and CEO of Joule. “We have the ability to deliver a suite of fungible, renewable fuels and chemicals at costs and quantities that could truly change industries. Troy joins at a very exciting time as we’ve generated a robust pipeline of world-class prospects that he will effectively manage and grow, leveraging direct expertise in structuring wide-ranging deals.”

“Joule has emerged with a practical, differentiated process that enables the direct photosynthetic production of renewable fuels and chemicals, overcoming the limitations of biomass-derived methods,” said Dr. Campione. “With a sustainable and cost-effective means of producing multiple end products, our options for commercialization will include product sales, partnerships and licensing.”

Joule’s Helioculture™ technology platform incorporates proprietary, genome-engineered organisms and a novel SolarConverter ™system to directly convert waste CO2 from industrial sources into multiple solar fuels and chemicals via the same cost-efficient process. Numerous end products have been validated to date, with drop-in replacement fuels being the first commercial targets. In addition to transportation fuels, Joule will pursue multi-billion dollar market opportunities that exist for renewable commodity and specialty chemicals.

About Joule Biotechnologies

Joule Biotechnologies, Inc. is tackling the global energy crisis with a game-changing, renewable alternative to transportation fuels. Its patent-pending Helioculture™ technology surpasses the limitations of biomass-derived fuel approaches by using sunlight to convert CO2 directly into Joule™ liquid energy. This direct-to-fuel conversion requires no fresh water and minimal non-agricultural land, avoids costly intermediaries and processing, and finally enables the scale, unlimited quantities and pricing required for energy independence. Founded in 2007 by Flagship Ventures, Joule is privately held and headquartered in Cambridge, Massachusetts. Additional information is available at www.joulebio.com.